Plain-English translation of NCT07404891 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study testing a new medication called , delivered as injections directly into the knee joint, for people with osteoarthritis. The study will compare the medication at two different doses against a placebo (inactive injection) to see if it reduces pain and improves how well your knee works. About 30 people will participate, and the entire study will take about 6 months.
Osteoarthritis causes chronic knee pain and stiffness that can limit daily activities, and current treatments don't work well for everyone. This trial is testing whether this medication can offer a new treatment option by reducing pain and improving joint function in people who haven't found relief with standard care.
You likely qualify if…
You likely don't qualify if…
You will receive 6 injections of the study medication (or placebo) directly into your knee, one injection every 2 weeks over a 10-week period. You'll visit the clinic 9 times total — once for screening, 6 times for injections, and 3 more times for follow-up visits over the next several weeks. At each visit, doctors will ask about your pain and knee function, and take measurements to track how you're improving. The entire study lasts about 6 months from start to finish.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China